Startseite Effects of co-administration of Unani pharmacopoeia formulations Qurs Tabasheer Sartani and Arq Hara Bhara with CAT-I antitubercular drugs in rats
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Effects of co-administration of Unani pharmacopoeia formulations Qurs Tabasheer Sartani and Arq Hara Bhara with CAT-I antitubercular drugs in rats

  • Noor Zaheer Ahmed , Hemanth Kumar Agibothu Kupparam , Seema Akbar , Syed Hissar , Noman Anwar , Kannan Thiruvengadam , Nighat Anjum , Asim Ali Khan , Showkat Dar und Saravanan Natarajan ORCID logo EMAIL logo
Veröffentlicht/Copyright: 10. Mai 2021

Abstract

Objectives

Tuberculosis continues to be a major public health problem globally, despite incredible advancements in healthcare system. In Unani system of medicine, Qurs Tabasheer Sarthani (QTS) and Arq Hara Bhara (AHB) have been traditionally used for tuberculosis like conditions. The study was aimed to investigate the effects of co-administration of QTS and AHB with category I first line antitubercular drugs (CAT-I) on the indices of liver and kidney function in rats.

Methods

QTS and AHB were prepared individually and mixed to achieve final compound Unani pharmacopoeia formulation (UPF). The human equivalent doses for rats were calculated and administered with and without CAT-I. The effects of the formulations on serum indices of kidney and liver function, hematological markers and plasma CAT-I drug levels were estimated at 14th, 60th & 180th days of treatment.

Results

The administration of UPF, CAT-I and UPF + CAT-I altered the levels of aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP) and gamma glutamyltransferase (GGT) and haematological markers. These alterations were within permissible range and randomly distributed among groups during various time points. Administration of CAT-I alone resulted in moderate histopathological changes which were completely abrogated in CAT-I + UPF co-administered animals. The co-administration of UPF with CAT-I improved the plasma peak rifampicin (RIF) levels, without altering the liver and kidney functions.

Conclusions

The co-administration of UPF with ATT improved liver and kidney functions and increased the plasma levels of RIF. These beneficial findings provide a scope to evaluate the pharmacokinetic studies in humans.


Corresponding author: Dr. Saravanan Natarajan, Scientist D, Head, Department of Biochemistry, National Institute for Research in Tuberculosis, ICMR, Chennai, India, Phone: +914428369676, Mobile: +919445636686, E-mail:

Funding source: Central Council for Research in Unani Medicine, New Delhi, Ministry of AYUSH, Govt. of India

Acknowledgments

The authors acknowledge Prof. S Shakir Jameel, former DG, CCRUM for his guidance in successful execution of the study, Dr. Shaik Nikhat, Dr M Abdul Kareem, Dr. Khalid Ghazanfar, Dr. Tazeen Nazir, and other officers from CCRUM and RRIUM Srinagar for their co-operation.

  1. Research funding: Central Council for Research in Unani Medicine, New Delhi, Ministry of AYUSH, Govt. of India.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: The authors declare that they have no competing interests.

References

1. World Health Organization. Global tuberculosis report 2017. Available at: https://www.who.int/tb/publications/global_report/gtbr2017_main_text.pdf?ua=1.Suche in Google Scholar

2. Harries, AD, Kumar, AMV, Satyanarayana, S, Lin, Y, Zachariah, R, Lonnroth, K, et al.. Addressing diabetes mellitus as part of the strategy for ending TB. Trans R Soc Trop Med Hyg 2016;110:173–9. https://doi.org/10.1093/trstmh/trv111.Suche in Google Scholar PubMed PubMed Central

3. Agal, S, Baijal, R, Pramanik, S, Patel, N, Gupte, P, Kamani, P, et al.. Monitoring and management of antituberculosis drug induced hepatotoxicity. J Gastroenterol Hepatol 2005;20:1745–52. https://doi.org/10.1111/j.1440-1746.2005.04048.x.Suche in Google Scholar PubMed

4. Awofeso, N. Anti-tuberculosis medication side-effects constitute major factor for poor adherence to tuberculosis treatment. Bull World Health Organ 2008;86:B–D. https://doi.org/10.2471/blt.07.043802.Suche in Google Scholar PubMed PubMed Central

5. Yee, D, Valiquette, C, Pelletier, M, Parisien, I, Rocher, I, Menzies, D. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. Am J Respir Crit Care Med 2003;167:1472–7. https://doi.org/10.1164/rccm.200206-626oc.Suche in Google Scholar PubMed

6. Mujahid, M, Hussain, T, Siddiqui, HH, Hussain, A. Evaluation of hepatoprotective potential of erythrinaindica leaves against antitubercular drugs induced hepatotoxicity in experimental rats. J Ayurveda Integr Med 2017;8:7–12. https://doi.org/10.1016/j.jaim.2016.10.005.Suche in Google Scholar PubMed PubMed Central

7. Jaswal, A, Sharma, M, Raghuvanshi, S, Sharma, S, Reshi, MS, Uthra, C, et al.. Therapeutic efficacy of Nigella sativa linn. Against antituberculosis drug induced hepatic injury in wistar rats. J Environ Pathol Toxicol Oncol 2016;35:59–71. https://doi.org/10.1615/jenvironpatholtoxicoloncol.2016013789.Suche in Google Scholar PubMed

8. Pal, R, Vaiphei, K, Sikander, A, Singh, K, Rana, SV. Effect of garlic on isoniazid and rifampicin-induced hepatic injury in rats. World J Gastroenterol 2006;12:636–9. https://doi.org/10.3748/wjg.v12.i4.636.Suche in Google Scholar PubMed PubMed Central

9. Eminzade, S, Uras, F, Izzettin, FV. Silymarin protects liver against toxic effects of anti-tuberculosis drugs in experimental animals. Nutr Metab (Lond) 2008;5:18. https://doi.org/10.1186/1743-7075-5-18.Suche in Google Scholar PubMed PubMed Central

10. Sherwani, AM, Mohammad Zulkifle, R. A pilot trial of jawarishamla as adjuvant to anti-tubercular treatment drugs for control of adverse reactions in dots regime in pulmonary TB. J IMA 2013;44:1–9. https://doi.org/10.5915/44-1-9988.Suche in Google Scholar PubMed PubMed Central

11. Kabiruddin, M. Bayaz-e-kabir. Lahore: HamdardKutubKhanaurdu Bazar, Matbatul Arabiya; 1921:110–2 pp.Suche in Google Scholar

12. Khan, A. Ramooz-e-Azam. New Delhi: Central Council for Research in Unani Medicine; 2006:319–24 pp.Suche in Google Scholar

13. Khan, A. Qarabadeen-e-Azam. New Delhi: Aijaz Publishing House; 1996:510–6 pp.Suche in Google Scholar

14. Arzani, MA. Qarabadeen-e-Qadri. New Delhi: Central Council for Research in Unani Medicine; 2009:442–3 pp.Suche in Google Scholar

15. Shin, JW, Seol, IC, Son, CG. Interpretation of animal dose and human equivalent dose for drug development. J Korean Med 2010;31:1–7.Suche in Google Scholar

16. Kumar, AK, Sudha, V, Ramachandran, G. Simple and rapid liquid chromatography method for simultaneous determination of isoniazid and pyrazinamide in plasma. SAARC J Tuberc Lung Dis HIV/AIDS 2012;9:13–8.10.3126/saarctb.v9i1.6960Suche in Google Scholar

17. Kumar, AK, Chandra, I, Geetha, R, Chelvi, KS, Lalitha, V, Prema, G. A validated high-performance liquid chromatography method for the determination of rifampicin and desacetyl rifampicin in plasma and urine. Indian J Pharmacol 2004;36:231–3.Suche in Google Scholar

18. Singh, S, Kumar, S. Tuberculosis in India: road to elimination. Int J Prev Med 2019;10:114. https://doi.org/10.4103/ijpvm.ijpvm_492_17.Suche in Google Scholar

19. Schaberg, T, Rebhan, K, Lode, H. Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis. Eur Respir J 1996;9:2026–30. https://doi.org/10.1183/09031936.96.09102026.Suche in Google Scholar

20. Ostapowicz, G, Fontana, RJ, Schiodt, FV, Larson, A, Davern, TJ, Han, HB, et al.. Results of a prospective study of acute liver failure at 17 Tertiary Care Centers in the United States. Ann Int Med 2002;137:947–54. https://doi.org/10.7326/0003-4819-137-12-200212170-00007.Suche in Google Scholar

21. Ramappa, V, Aithal, GP. Hepatotoxicity related to anti-tuberculosis drugs: mechanisms and management. J Clin Exp Hepatol 2013;3:37–49. https://doi.org/10.1016/j.jceh.2012.12.001.Suche in Google Scholar

22. Baniasadi, S, Eftekhari, P, Tabarsi, P, Fahimi, F, Raoufy, MR, Masjedi, MR, et al.. Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity. Eur J Gastroenterol Hepatol 2010;22:1235–38. https://doi.org/10.1097/meg.0b013e32833aa11b.Suche in Google Scholar

23. Hasanain, AF, Zayed, AH, Mahdy, RE, Nafee, AM. Cholecalciferol for prophylaxis against antituberculosis therapy-induced liver disorders among naive patients with pulmonary tuberculosis: a randomized, comparative study. Int J Mycobacteriol 2017;6:149–55. https://doi.org/10.4103/ijmy.ijmy_19_17.Suche in Google Scholar

24. Adhvaryu, MR, Reddy, N, Vakharia, BC. Prevention of hepatotoxicity due to anti tuberculosis treatment: a novel integrative approach. World J Gastroenterol 2008;14:4753–62. https://doi.org/10.3748/wjg.14.4753.Suche in Google Scholar

25. Ormerod, LP, Horsfield, N. Frequency and type of reactions to antituberculosis drugs: observations in routine treatment. Tuber Lung Dis 1996;77:37–42. https://doi.org/10.1016/s0962-8479(96)90073-8.Suche in Google Scholar

26. Ravishah, S, Manjula, SN, Mruthunjaya, K, Krishnanand, P, Pramod, CK, Madhu, RM, et al.. Hepatoprotective activity of roots of Lawsonia inermis against paracetamol and antitubercular drugs induced hepatotoxicity in rats. Int J Pharm 2012;2:306–16.Suche in Google Scholar

27. Kassa, E, Enawgaw, B, Gelaw, A, Gelaw, B. Effect of anti-tuberculosis drugs on hematological profiles of tuberculosis patients attending at university of Gondar Hospital, Northwest Ethiopia. BMC Hematol 2016;16:1–11. https://doi.org/10.1186/s12878-015-0037-1.Suche in Google Scholar PubMed PubMed Central

28. Yue, J, Peng, R, Yang, J, Kong, R, Liu, J. CYP2E1 mediated isoniazid-induced hepatotoxicity in rats. Acta Pharmacol Sin 2004;25:699–704.Suche in Google Scholar

29. Acocella, G. Pharmacokinetics and metabolism of rifampin in humans. Rev Infect Dis 1983;5:S428–32. https://doi.org/10.1093/clinids/5.supplement_3.s428.Suche in Google Scholar PubMed

30. Burk, O, Koch, I, Raucy, J, Hustert, E, Eichelbaum, M, Brockmoller, J, et al.. The induction of cytochrome P450 3A5 (CYP3A5) in the human liver and intestine is mediated by the xenobiotic sensors pregnane X receptor (PXR) and constitutively activated receptor (CAR). J Biol Chem 2004;279:38379–85. https://doi.org/10.1074/jbc.m404949200.Suche in Google Scholar

31. Sarma, GR, Immanuel, C, Kailasam, S, Narayana, AS, Venkatesan, P. Rifampin-induced release of hydrazine from isoniazid. A possible cause of hepatitis during treatment of tuberculosis with regimens containing isoniazid and rifampin. Am Rev Respir Dis 1986;133:1072–5. https://doi.org/10.1164/arrd.1986.133.6.1072.Suche in Google Scholar PubMed

Received: 2020-07-23
Accepted: 2020-09-17
Published Online: 2021-05-10

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Reviews
  3. ‘Ilāj bi’l-Tadbīr (regimenal therapy): a core mode of Unani treatment
  4. Understanding hormones in terms of humours (Akhlat) in Unani system of medicine
  5. Review Articles
  6. Understanding Humma-e-Wabai (epidemic fever) and Amraz-e-Wabai (epidemic disease) in the light of Unani medicine
  7. Emergence of antimicrobial resistance and magnitude of Unani medicine – scope and challenges
  8. Medicinal importance of Papra (Podophyllum hexandrum Royle) in Unani System of Medicine
  9. Research Articles
  10. Comparative effects of berberine and piperine on the neuroprotective potential of neostigmine
  11. Neera, a non-fermented traditional drink from coconut spadix restores the redox status in sodium fluoride intoxicated mice
  12. Evaluation of wound healing potential of Bhallatakadi Ghrita – cow ghee based polyherbal formulation: in-vivo excision and incision wound model
  13. Effects of co-administration of Unani pharmacopoeia formulations Qurs Tabasheer Sartani and Arq Hara Bhara with CAT-I antitubercular drugs in rats
  14. Neurotoxicity of organic solvents with emphasis on the role of iron
  15. Regular consumption of “Nkui”, a Cameroonian traditional dish, may protect against cardiovascular and bone disorders in an estrogen deficiency condition
  16. A spatial-temporal study of complementary and alternative medicine (CAM) by type: exploring localization economies implications in urban areas in Ontario
  17. Complementary and alternative interventions for stroke recovery – a narrative overview of the published evidence
  18. The feasibility and acceptability of hypnotherapy among overweight and obese individuals in a Malaysia’s public university
  19. Effectiveness of wet cupping therapy on relieving pain in patients with chronic migraine: an observational study
  20. Effect of aromatherapy massage by orange essential oil on post-cesarean anxiety: a randomized clinical trial
  21. Effect of Sudarshan Kriya Yoga (SKY) on daytime and situational sleep propensity in novice practitioners: a prospective cohort study
  22. Comparison of instability resistance training, traditional resistance training and plyometric training on athletic performance parameters
  23. Individualized homeopathic medicines and Urtica urens mother tincture in treatment of hyperuricemia: an open, randomized, pragmatic, pilot trial
  24. Association of microsomal epoxide hydrolase gene (fast genotype) with lung functions impairment in wood workers
  25. Dietary glycine improves urine storage symptoms in urology outpatients
  26. Hypoxia-induced oxidative stress in high altitude population: impact of coenzyme Q10 supplementation
  27. Short Communications
  28. Terminalia arjuna induced testicular assault through Leydig cell derangement: an in vitro approach
  29. Effect of acupuncture on cognitive task performance of college students: a pilot study
  30. Yoga for children in the new normal – experience sharing
  31. Effect of Arogya Raksha Panchatantra (five lifestyle principles) on hematological parameters and anthropometric measures among healthy volunteers: a pilot study
  32. Case Reports
  33. Yellow phosphorous ingestion cause liver dysfunction and internal bleeding: a case study
  34. Effect of yoga on plasma glucose, lipid profile, blood pressure and insulin requirement in a patient with type 1 diabetes mellitus
  35. Management of Vipadika with Mahisha Gritha Padanimajjana – a case report
Heruntergeladen am 11.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jcim-2020-0262/html
Button zum nach oben scrollen